Dosing will be a key success factor in repurposing antivirals for COVID-19.

Smith, Patrick F; Dodds, Michael; Bentley, Darren; Yeo, Karen; Rayner, Craig

Smith, Patrick F; Dodds, Michael; Bentley, Darren; Yeo, Karen; Rayner, Craig.

Smith PF; Certara, Princeton, New Jersey, USA.
Dodds M; Certara, Princeton, New Jersey, USA.
Bentley D; Certara UK Limited, Sheffield, South Yorkshire, UK.
Yeo K; Certara UK Limited, Sheffield, South Yorkshire, UK.
Rayner C; Certara, Princeton, New Jersey, USA.

Br J Clin Pharmacol ; 87(9): 3451-3454, 2021 09.

Article in English | MEDLINE | ID: covidwho-72396

Subject(s)

Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Antiviral Agents/administration & dosage; Antiviral Agents/therapeutic use; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Repositioning / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14314

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google